DR HORTON INC

Warren Buffett’s Berkshire Hathaway adds D.R. Horton to its portfolio, signaling a strategic real‑estate tilt amid resilient U.S. home‑building demand.

Real‑estate stocks rally on CPI‑aligned inflation easing, while consumer‑discretionary falters after earnings warnings and exec changes—diversified portfolios thrive amid shifting macro cues.

DR Horton’s Q3 earnings: flat revenue, modest profit dip, yet EPS tops forecasts—showing resilient market share and growth opportunities in energy‑efficient homes.

Florida’s property‑tax overhaul could slash homeowner costs and give builders a $2,500 credit, but the proposal’s fiscal, legal and market risks mean investors must weigh its long‑term impact.

Explore how soaring U.S. mortgage rates hit homebuilder stocks, reveal hidden risks & new growth avenues like modular construction and digital sales.

DR Horton’s April 21 earnings reveal a strategic pivot: digital‑physical integration, smart‑home upgrades, and experience‑centric living reshape its growth outlook amid changing consumer habits.

DR Horton’s Q1 2026 earnings signal a modest revenue dip yet sharper EPS decline, driven by rising labor/material costs, tightening regulations, and build‑tech competition—investors should watch margin strategy, debt levels, and regulatory complianc…

DR Horton’s April 2026 single‑family home sale highlights how compliance, sustainability, and digital sales tools are reshaping the home‑building market.

Archer Investment Corp’s purchase of 1,700 D.R. Horton shares shows a cautious bet on the U.S. home‑building market, weighing cost pressures, regulatory changes and tech adoption ahead of DHI’s April earnings.

DR Horton’s recent share dip reflects a sector‑wide pullback amid rising mortgage rates and inflation, yet its scale and land‑bank strengths may cushion the impact for investors.